Preliminary Pharmacokinetics (Pk), Safety And Efficacy Of Two Dosing Regimens Of Cs1003 (Anti-Pd-1) In Solid Tumours: 200 Mg Every 3-Week (Q3w) And 400 Mg Every 6-Week (Q6w) Dosing
Annals of Oncology(2020)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要